scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1046724478 |
P356 | DOI | 10.1186/1471-2334-13-60 |
P932 | PMC publication ID | 3574834 |
P698 | PubMed publication ID | 23374914 |
P5875 | ResearchGate publication ID | 235395176 |
P50 | author | Ulisses Ramos Montarroyos | Q90154245 |
Celina Maria Turchi Martelli | Q28678095 | ||
Maria Regina Cardoso | Q42822686 | ||
Cynthia Braga | Q54438288 | ||
P2093 | author name string | Airton T Stein | |
Ricardo A A Ximenes | |||
Leila M M B Pereira | |||
Gerusa M Figueiredo | |||
Marcelo Costa | |||
Marília D Turchi | |||
Gabriela Coral | |||
Regina C Moreira | |||
Alex A dos Santos | |||
Deborah Crespo | |||
Edgar Merchan-Hamman | |||
Luis Claudio A Alencar | |||
Maria Luiza C Lima | |||
P2860 | cites work | Epidemiology of hepatitis C virus infection | Q22305500 |
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus | Q24596340 | ||
Global epidemiology of hepatitis C virus infection | Q27860799 | ||
Population-based multicentric survey of hepatitis B infection and risk factor differences among three regions in Brazil | Q84301030 | ||
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 | Q29620136 | ||
Profile of cocaine and crack users in Brazil | Q33370103 | ||
Surveillance for acute viral hepatitis - United States, 2007. | Q34983660 | ||
Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies | Q36346436 | ||
Estimating the population attributable risk for multiple risk factors using case-control data | Q36499362 | ||
Multilevel analysis of hepatitis A infection in children and adolescents: a household survey in the Northeast and Central-west regions of Brazil | Q36790019 | ||
Surveillance and epidemiology of hepatitis B and C in Europe - a review. | Q37257831 | ||
Epidemiology of hepatitis B and C viruses: a global overview | Q37685594 | ||
Methodology of a nationwide cross-sectional survey of prevalence and epidemiological patterns of hepatitis A, B and C infection in Brazil | Q37793952 | ||
Trends and projections of hepatitis C virus epidemiology in Latin America. | Q37886279 | ||
Hepatitis C prevalence and risk factors in hemodialysis patients in Central Brazil: a survey by polymerase chain reaction and serological methods. | Q38932442 | ||
Prevalence, risk factors and genotypes of hepatitis C virus infection among drug users, Central-Western Brazil. | Q39188838 | ||
Prevalence of hepatitis B and C serological markers among first-time blood donors in Brazil: a multi-center serosurvey | Q39294392 | ||
Prevalence of hepatitis C virus infection in north-eastern Brazil: a population-based study | Q39740919 | ||
Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: social factors are important predictors after adjusting for known risk factors. | Q39920086 | ||
Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004. | Q42978282 | ||
Prevalence, genotypes and risk factors associated with hepatitis C virus infection in hemodialysis patients in Campo Grande, MS, Brazil | Q42980341 | ||
Epidemiological and genetic analyses of Hepatitis C virus transmission among young/short- and long-term injecting drug users from Rio de Janeiro, Brazil | Q42985074 | ||
Geographic distribution of hepatitis C virus genotypes in Brazil | Q42990198 | ||
High prevalence of hepatitis C associated with familial history of hepatitis in a small town of south Brazil: efficiency of the rapid test for epidemiological survey | Q43032959 | ||
IL28B polymorphism associated with spontaneous clearance of hepatitis C infection in a Southern Brazilian HIV type 1 population. | Q43039016 | ||
Comparison between two household surveys on psychotropic drug use in Brazil: 2001 and 2004. | Q43065257 | ||
The impact of the prevention programme of hepatitis C over more than a decade: the French experience | Q43271372 | ||
Assessment and proposal of a new combination of screening criteria for hepatitis C in France | Q43295179 | ||
High prevalence of genotype 1 in individuals with hepatitis C in Belo Horizonte, MG | Q44224943 | ||
Epidemiological profile of cocaine users on treatment in psychiatrics hospitals, Brazil | Q44686968 | ||
Health conditions and health-policy innovations in Brazil: the way forward | Q56783487 | ||
Acute hepatitis C virus infection | Q58324396 | ||
Estimating future hepatitis C morbidity, mortality, and costs in the United States | Q73073538 | ||
Estimated Prevalence of Viral Hepatitis in the General Population of the Municipality of São Paulo, Measured by a Serologic Survey of a Stratified, Randomized and Residence-Based Population | Q73260324 | ||
Tattoos and transfusion-transmitted disease risk: implications for the screening of blood donors in Brazil | Q74692083 | ||
P921 | main subject | Brazil | Q155 |
hepatitis C | Q154869 | ||
Hepatitis C virus | Q708693 | ||
P304 | page(s) | 60 | |
P577 | publication date | 2013-02-01 | |
P1433 | published in | BMC Infectious Diseases | Q15759919 |
P1476 | title | Prevalence and risk factors of Hepatitis C virus infection in Brazil, 2005 through 2009: a cross-sectional study | |
P478 | volume | 13 |
Q36732492 | A Cross Section Study to Determine the Prevalence of Antibodies against HIV Infection among Hepatitis B and C Infected Individuals |
Q47549364 | A Cross-Sectional Study of Viral Hepatitis Perception among Residents from Southeast and North Regions of Brazil |
Q61958644 | Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission |
Q40101028 | Age-standardized mortality rates related to viral hepatitis in Brazil. |
Q35247372 | Association of a variant in the regulatory region of NADPH oxidase 4 gene and metabolic syndrome in patients with chronic hepatitis C |
Q44835949 | Burden of liver disease in Brazil |
Q26773585 | Chronic Hepatitis C: An Overview of Evidence on Epidemiology and Management from a Brazilian Perspective |
Q37654449 | Chronic hepatitis C genotype 1 virus: who should wait for treatment? |
Q40194957 | Contrasting HCV and HIV seroepidemiology in 11 years of blood donors screening in Brazil. |
Q38675898 | Cross-Sectional Study to Determine the Prevalence of Hepatitis B and C Virus Infection in High Risk Groups in the Northeast Region of Brazil. |
Q60046383 | Current trends of liver cirrhosis in Mexico: Similitudes and differences with other world regions |
Q58736665 | Determination of hepatitis B, C and D prevalence among urban and Amerindian populations from the Eastern Brazilian Amazon: a cross sectional study |
Q33828630 | Epidemiological aspects of HCV infection in non-injecting drug users in the Brazilian state of Pará, eastern Amazon |
Q40470429 | Epidemiology of Hepatitis B and Hepatitis C Infections and Benefits of Programs for Hepatitis Prevention in Northeastern China: A Cross-Sectional Study. |
Q36923004 | Evidence of association between hepatitis C virus genotype 2b and nosocomial transmissions in hemodialysis centers from southern Brazil. |
Q40043745 | Exposure source prevalence is associated with gender in hepatitis C virus patients from Rio de Janeiro, Brazil |
Q36253099 | Exposure to hepatitis C virus in homeless men in Central Brazil: a cross-sectional study. |
Q92438474 | HCV genotype profile in Brazil of mono-infected and HIV co-infected individuals: A survey representative of an entire country |
Q28538943 | HCV genotypes, characterization of mutations conferring drug resistance to protease inhibitors, and risk factors among blood donors in São Paulo, Brazil |
Q56447266 | HIV & Hepatitis in the Americas 28-30 April 2016, Mexico City, Mexico |
Q34696503 | Health care-associated hepatitis C virus infection |
Q92494930 | Hepatitis B and C prevalence and risk factors among young men presenting to the Brazilian Army: A STROBE-compliant national survey-based cross-sectional observational study |
Q36221999 | Hepatitis C Seroprevalence and Risk Factors in Adult Population of Chaharmahal and Bakhtiari Province of Iran in 2013 |
Q33578932 | Hepatitis C among blood donors: cascade of care and predictors of loss to follow-up. |
Q91923119 | Hepatitis C in Hemodialysis Units: diagnosis and therapeutic approach |
Q26795645 | Hepatitis C in key populations in Latin America and the Caribbean: systematic review and meta-analysis |
Q89635094 | Hepatitis C screening, diagnosis, and cascade of care among people aged > 40 years in Brasilia, Brazil |
Q45324439 | Hepatitis C virus infection among illicit drug users in an archipelago of the Amazon. |
Q91964344 | Hepatitis C virus infection status and associated factors among a multi-site sample of people who used illicit drugs in the Amazon region |
Q37735774 | Hepatitis C virus pharmacogenomics in Latin American populations: implications in the era of direct-acting antivirals |
Q51837887 | Hepatitis C worldwide and in Brazil: silent epidemic--data on disease including incidence, transmission, prevention, and treatment. |
Q40772386 | Hepatitis C: Prevalence of serologic markers and risk factors in blood donors at a large blood centre in South-eastern Brazil (2007-2010). |
Q38203033 | Historical epidemiology of hepatitis C virus (HCV) in selected countries. |
Q38477511 | IFN-λ gene polymorphisms as predictive factors in chronic hepatitis C treatment-naive patients without access to protease inhibitors |
Q40202784 | Incidence of hepatitis C in Brazil. |
Q42213221 | Knowledge and prevalence of viral hepatitis among beauticians. |
Q91940752 | Los nuevos tratamiento de hepatitis C: Perspectivas latinoamericanas |
Q33908680 | Low prevalence of hepatitis B and C virus markers among children and adolescents |
Q47562866 | Making the invisible visible: searching for human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) in Brazilian patients with viral hepatitis B and C. |
Q41653846 | NS5A inhibitor resistance-associated polymorphisms in Brazilian treatment-naive patients infected with genotype 1 hepatitis C virus |
Q39307349 | Natural occurrence of NS5B inhibitor resistance-associated variants in Brazilian patients infected with HCV or HCV and HIV. |
Q91940747 | New therapies for hepatitis C: Latin American perspectives |
Q36359337 | Population-Based Multicentric Survey of Hepatitis B Infection and Risk Factors in the North, South, and Southeast Regions of Brazil, 10-20 Years After the Beginning of Vaccination |
Q42283670 | Prevalence and factors associated with HCV infection among elderly individuals in a southern Brazilian city. |
Q33600962 | Prevalence and trends of markers of hepatitis B virus, hepatitis C virus and human Immunodeficiency virus in Argentine blood donors |
Q40089143 | Prevalence of Hepatitis B and C virus infection among alcoholic individuals: importance of screening and vaccination |
Q64092009 | Prevalence of hepatitis B and hepatitis C among diabetes mellitus type 2 individuals |
Q37705730 | Prevalence of hepatitis C virus and human immunodeficiency virus in a group of patients newly diagnosed with active tuberculosis in Porto Alegre, Southern Brazil |
Q59801984 | Prevalence of serological markers for hepatitis and potential associated factors in patients with diabetes mellitus |
Q90319117 | Seroepidemiology and risk factors of hepatitis C virus infection in East Azerbaijan, Iran: a population-based Azar Cohort study |
Q30241549 | Seroprevalence of hepatitis C virus among people living with HIV/AIDS in Latin America and the Caribbean: a systematic review |
Q59437013 | State of viral hepatitis knowledge and testing uptake in Brazil: Findings from the National Survey of Knowledge, Attitudes and Practices (PCAP-2013) |
Q34802769 | The association between neighborhood residential rehabilitation and injection drug use in Baltimore, Maryland, 2000-2011 |
Q39213684 | The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm |
Q35149320 | The prevalence of hepatitis C virus infection and its related risk factors among the rural population of fars province, southern iran. |
Q34263352 | Vertical transmission of hepatitis C virus: Current knowledge and perspectives |
Q26782000 | What's new in hepatitis C virus infections in children? |
Q41360324 | Worldwide distribution of the NS3 gene 80K polymorphism among circulating hepatitis C genotype 1 viruses: implication for simeprevir usage |
Search more.